Darren L. Asquith

3.1k citations
23 papers · 2.6k indexed · 2 hit papers · h-index 17
Topics
IL-33, ST2, and ILC Pathways (5 papers)Psoriasis: Treatment and Pathogenesis (5 papers)Rheumatoid Arthritis Research and Therapies (4 papers)

In The Last Decade

Darren L. Asquith

23 papers receiving 2.5k citations

Hit Papers

IL-33 reduces the development of atherosclerosis200820262014202020082011100200300400500

Peers

Darren L. Asquith
Comparison fields: 5 of 109
  • Immunology 1.5k
  • Molecular Biology 669
  • Surgery 572
  • Rheumatology 499
  • Cancer Research 372
Replace Régis Brion with:
Régis Brion France
Wang‐Dong Xu China
Kunihiro Ichinose Japan
Yoriaki Kaneko Japan
Hae‐Rim Kim South Korea
Seon-Yeong Lee South Korea
Stefano Alivernini Italy
Jianqin Ye United States
Fanlei Hu China
Gabriel Criado Spain
Darren L. Asquith relative to Régis Brion France Régis Brion's profile →
Citations per field
00.5×1.5×1.8×
Régis Brion · 1×
Citations per year

Countries citing papers authored by Darren L. Asquith

Since Specialization
Citations

This map shows the geographic impact of Darren L. Asquith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren L. Asquith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren L. Asquith more than expected).

Fields of papers citing papers by Darren L. Asquith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darren L. Asquith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren L. Asquith. The network helps show where Darren L. Asquith may publish in the future.

Co-authorship network of co-authors of Darren L. Asquith

This figure shows the co-authorship network connecting the top 25 collaborators of Darren L. Asquith. A scholar is included among the top collaborators of Darren L. Asquith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darren L. Asquith. Darren L. Asquith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Effect of Long-Term Treatment with Secukinumab on Cardio-Metabolic Profile in Patients with Active Ankylosing Spondylitis and Psoriatic Arthritis: Pooled 3 Year Analysis
1
2 13
3 1
4 55
5 55
6 31
7 36
8 56
9 28
10
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritisbreakdown →
503
11 21
12 137
13 304
14 14
15 20
16 276
17 42
18 272
19
IL-33 reduces the development of atherosclerosisbreakdown →
543
20 69

About Darren L. Asquith

Darren L. Asquith is a scholar working on Immunology, Rheumatology and Immunology and Allergy, having authored 23 papers that have together received 2.6k indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). The work is most often cited by research in Immunology (1.5k citations), Rheumatology (499 citations) and Cancer Research (372 citations). Darren L. Asquith has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Iain B. McInnes, Ashley M. Miller, Foo Y. Liew, Axel J. Hueber, Naveed Sattar, Damo Xu, Andrew H. Baker, Laura Denby, Yubin Li and James H. Reilly. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026